SparingVision Conference Participation in H1 2024

SparingVision Conference Participation in H1 2024

Paris, December 12, 2023 – SparingVision (“the Company”),

a clinical-stage genomic medicine company transforming the treatment of retinal disease, today announces upcoming conferences that its management team will be participating in in the first half of 2024:

Investor and Industry Conferences:

JP Morgan 41st Annual Healthcare Conference, San Francisco, California, US – 8-11 January

Degroof Petercam Healthcare Conference, Virtual – 23-26 January

Invest in Cures, San Francisco California, US – 7 February

Gene Therapy for Rare Disorders, Boston, Massachusetts, US – 26-29 March

Cell & Gene Meeting on the Mediterranean, Rome, Italy – 9-11 April

CMO Summit 2024, Boston, Massachusetts, US – 17-18 April

Scientific & Medical Conferences:

Hawaiian Eye & Retina, Maui, Hawaii, US – 13-19 January

Macula Society Annual Conference, Palm Springs, California, US – 7-10 February

APAO (Asia-Pacific Academy of Ophthalmology), Bali, Indonesia – 22-25 February

ARVO (Association for Research in Vision and Ophthalmology), Seattle, Washington, US – 5-9 May

ASGCT (American Society of Gene and Cell Therapy), Baltimore, Maryland, US – 7-11 May


Patient Associations Conferences:

Investing in the Cures Summit, Scottsdale, Arizona, US – 8-9 March

Retinal Cell & Gene Innovation Summit, Seattle, Washington, US – 3 May

Retina International World Congress, Dublin, Ireland – 5-8 June

VISIONS 2024, Chicago, Illinois, US – 21-22 June